Online Database of Chemicals from Around the World Search | Submit | Advertise

Home >> Chemical Listing >> Retaspimycin hydrochloride>> Market Analysis Reports
 

Market Analysis Reports of Retaspimycin hydrochloride

Infinity Pharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis
... ’s primary product candidate, IPI-504 (retaspimycin hydrochloride), is an intravenously-administered small molecule inhibitor ... of Hsp90. IPI-504 (retaspimycin hydrochloride) is a small molecule, semi-synthetic analog ...

Drivers of M&A in 2013-2016: PI3Ks and BTK Inhibitors
Targeting kinases have been on the agenda of most drug developers/ researchers as they hold the key path to signaling, development and growth of the cell. Tumors/cancer biology indicates that this balance is disturbed and inhibiting the aberrant pathways ...




Copyright ©  chemBlink. All rights reserved. Content Disclaimer | about chemBlink | Contact